White Papers and Application Notes

Solutions for Monoclonal Antibody (mAb) Therapy Discovery and Development

Solutions for Monoclonal Antibody (mAb) Therapy Discovery and Development

The use of therapeutic antibodies has shown promise as an effective cancer treatment strategy

Sartorius

The discovery and development of next-generation  monoclonal antibodies for cancer immunotherapy relies on rapid, information-rich solutions that offer deeper biological insights than current strategies. Sartorius's information-rich solutions for antibody therapy development enable tracking of complex biological processes at unprecedented speed, depth, and scale, instilling confidence in the choice and integrity of your therapy

Download the paper to learn more about:

  • Engineering for enhanced cytotoxicity
  • In-depth insights for next-generation antibody
    development
  • Immune cell re-targeting with bi-specific mAbs

Access this paper to  learn more about solutions for
mAb therapy discovery and development.